Dr. Pompili earned his medical degree at Case Western Reserve University School of Medicine in Cleveland, Ohio, and completed his residency in internal medicine at The John Hopkins University in Baltimore, Md. Dr. Pompili also completed a fellowship in cardiovascular medicine at the University of Michigan in Ann Arbor, Mich., and a fellowship in interventional cardiology at Mayo Clinic in Rochester, Minn.
Dr. Pompili has published many abstracts, articles and peer-reviewed manuscripts in prestigious peer-reviewed journals including Science and Circulation. Over the past eight years, Dr. Pompili has pioneered novel approaches of research in the areas of translational stem cell therapies for patients with severe cardiovascular and peripheral vascular disease.
He has successfully completed the third U.S. FDA-approved NIH-sponsored trial in cardiovascular stem cell therapy and currently is actively investigating cell therapy options in the setting of phase I and phase II clinical trials.
Dr. Pompili’s clinical interests include complex interventional cardiology and management of acute coronary syndromes, and his research focuses on translational cardiovascular regenerative medicine and stem cell therapeutics. Dr. Pompili was named one of America’s Best Doctors in 2009.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2016
Case Western Reserve University School of Medicine
Johns Hopkins Hospital
7/1/1989 - 6/30/1991
Specialties and conditions I treat
- Interventional Cardiology
- Cardiac Catheterization
- Percutaneous Coronary Intervention
- Acute Coronary Syndrome
- Cardiovascular Diseases
- Coronary Care Units
- Angioplasty, Balloon
- Angioplasty, Balloon, Coronary
- Coronary Artery Disease
- Coronary Disease
- Heart Valve Diseases
Locations where I practice
More about my work
6/25/1994 - 6/30/1995
University of Michigan Hospitals
7/1/1991 - 6/30/1994
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Cardiovascular)
American Board of Internal Medicine (Subspecialty: Interventional Cardiology)
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Pompili has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Arteriocyte Medical Systems, Inc.
- Arteriocyte, Inc.
- Boston Scientific
- Cardinal Health, Inc.